Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...
Researchers have found that Artemisia herba-alba, a medicinal herb, contains compounds capable of fighting colorectal cancer.
Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...
Scientists from the University of Sharjah have found that a naturally growing aromatic plant contains ingredients with the ...
MedPage Today on MSN13d
Practice-Changing Win for Aspirin in Colorectal CancerSAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on ...
HealthDay on MSN10d
Daily Aspirin Reduces Colon Cancer Risk: StudyDaily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new stu ...
StudyFinds on MSN11d
Desert plant shows promise as colorectal cancer treatmentA common aromatic shrub that has served as traditional medicine for centuries could point the way toward innovative treatments for colorectal cancer ...
HealthDay on MSN7d
Daily, Long-Term Aspirin Use Reduces Colorectal Cancer RecurrenceAdjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer ...
Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback